Vigil Neuroscience, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VIGL research report →
Range $8 – $11
Price Chart
About the company
Vigil Neuroscience, Inc. , founded in 2020 and headquartered in Cambridge, Massachusetts, is a biotechnology company concentrating on microglia to develop transformative treatments for neurodegenerative diseases. The firm aims to provide disease-altering therapies for patients, their families, and caregivers affected by both rare and widespread neurological disorders.
- CEO
- Ivana Magovcevic-Liebisch
- IPO
- 2022
- Employees
- 69
- HQ
- Watertown, MA, US
Get TickerSpark's AI analysis on VIGL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $375.71M
- P/E
- -3.89
- PEG
- -2.96
- P/S
- 0.00
- P/B
- 4.57
- EV/EBITDA
- -4.17
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -89.69%
- ROIC
- -106.03%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-453,000-13.5%
- Op Income
- $-89,683,000
- Net Income
- $-84,256,000-2.0%
- EPS
- $-2.07+2.8%
- OCF Growth
- +27.2%
- FCF Growth
- +27.9%
- 52W High
- $8.10
- 52W Low
- $1.31
- 50D MA
- $7.97
- 200D MA
- $3.80
- Beta
- 3.34
- RSI (14)
- 79
- Avg Volume
- 1.65M
No earnings-call transcripts are available for VIGL yet.
- Free Float
- 67.0%
- Shares Outstanding
- 46.67M
- Float Shares
- 31.28M
of shares held by institutions
50 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Northpond Ventures, LLC | 4.21M | 0 |
| Blackrock Inc. | 405.04K | ▼ 471.99K |
| Peak6 Investments LLC | 41.49K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 5, 25 | Atlas Venture Fund XII, L.P. | sell | 1,027,978 |
| Aug 5, 25 | Thistle Mary | sell | 18,068 |
| Aug 5, 25 | Thistle Mary | sell | 12,155 |
| Aug 5, 25 | Thistle Mary | sell | 5,000 |
| Aug 5, 25 | Kaufmann Petra | sell | 144,000 |
| Aug 5, 25 | Kaufmann Petra | sell | 330,000 |
| Aug 5, 25 | Budd Haeberlein Samantha L. | sell | 18,068 |
| Aug 5, 25 | Budd Haeberlein Samantha L. | sell | 30,694 |
| Aug 5, 25 | Budd Haeberlein Samantha L. | sell | 12,000 |
| Aug 5, 25 | Ziolkowski Jennifer Lynn | sell | 135,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VIGL coverage
Recent articles, reports, and earnings notes.
No research on VIGL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VIGL report →VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
businesswire.com · Jul 14
Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High?
zacks.com · Jun 25
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders
prnewswire.com · Jun 9
Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet
zacks.com · Jun 9
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm
prnewswire.com · Jun 4
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
globenewswire.com · Jun 4
Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?
zacks.com · Jun 2
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
globenewswire.com · May 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.